DrugDashboards

Capecitabine

Capecitabine · CAPECITABINE 150 mg/1 · Tablet, Film Coated · Oral · Teva Pharmaceuticals USA, Inc.

NDC 00093-7473-06 · 60 TABLET, FILM COATED in 1 BOTTLE · ANDA · View full market →

The short version

17 companies supply this market — deep enough that no single failure threatens the supply. The price is up 19% over the past year, to $0.3615 per unit. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.3615per EAinvoice-surveyed acquisition cost · Jun 17, 2026
  • Medicare Part B pays (ASP+6%)$0.0800per billing unit (50 MG)HCPCS J8522 · Jul 1, 2026
  • Part D plans paid (avg)$2.99per dosage unitgross, before rebates — matched by drug name · 2024
  • Medicaid generic ceiling (FUL)$0.3615per TABweighted avg manufacturer price $0.2063 · Aug 1, 2026100% of what pharmacies pay — higher than 10% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$5.00$10.00Nov 2014Sep 2026$0.3615
24 price points · per EA · held since Jun 17, 2026 · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

#30 count
$10.85
#90 count
$32.54

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicare Part B (ASP)

Payment limit per 50 MG
$0.080
HCPCS J8522 · Jul 1, 2026 quarter · typically ASP + 6%

Medicaid spend (2023)

$1,167
27 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

0● Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for capecitabine (oral solid) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA091649
TE code
AB
Approval date
Sep 16, 2013
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class II · TerminatedDec 21, 2015
    Teva North America — Failed Dissolution Specifications: low test results at the 18 month time-point

Manufacturers of Capecitabine (Tablet, Film Coated)

LabelerStrengthFirst seenLast seen
BluePoint LaboratoriesCAPECITABINE 500 mg/1Jul 15, 2026Sep 3, 2026
BluePoint LaboratoriesCAPECITABINE 150 mg/1Jul 15, 2026Sep 3, 2026
Accord Healthcare Inc.CAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Accord Healthcare Inc.CAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
American Health PackagingCAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Armas Pharmaceuticals Inc.CAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Armas Pharmaceuticals Inc.CAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Ascend Laboratories, LLCCAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Ascend Laboratories, LLCCAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.CAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.CAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Cipla USA Inc.CAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Cipla USA Inc.CAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
CivicaScript LLCCAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
CivicaScript LLCCAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Excella GmbH & Co. KGCAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Golden State Medical Supply, Inc.CAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Golden State Medical Supply, Inc.CAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
H2-Pharma, LLCCAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Lifestar Pharma LLCCAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Lifestar Pharma LLCCAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
NorthStar RxLLCCAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Novadoz Pharmaceuticals LLCCAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Novadoz Pharmaceuticals LLCCAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.CAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.CAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.CAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.CAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026
Teyro Labs Private LimitedCAPECITABINE 150 mg/1Jul 15, 2026Sep 2, 2026
Teyro Labs Private LimitedCAPECITABINE 500 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Capecitabine — NDC 00093-7473-06," retrieved September 3, 2026, https://drugdashboards.com/drug/00093747306.

Free to cite with attribution — see how the data is put together.